Discovery Capital Funding
Minneapolis, Minnesotaresearch.umn.edu
Overview
Discovery Capital is an early-stage, matching equity investment program sponsored by the University of Minnesota's Research & Innovation Office. It provides equity investments to startups built around licensed UMN technologies, co-investing alongside experienced Venture Capitalists to reduce early-stage risk and accelerate commercialization. The program's goals include strengthening the university's startup ecosystem, increasing the commercialization of UMN research, and driving economic impact in Minnesota. The program requires startups to have a lead investor before it provides matching funds.
Portfolio Companies
6
Website
research.umn.eduInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Låkril Technologies | Jun 2025 | Seed | Co-investor |
| SecondWave Systems, Inc. | Apr 2025 | Series A | Co-investor |
| Jord BioScience | Feb 2025 | Series B | Co-investor |
| Phoam Labs | Sep 2024 | Seed | Co-investor |
| Brightstar Therapeutics | Apr 2023 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.